ZEISS Medical Technology has entered a strategic collaboration with Envision Health Technologies to advance glaucoma care through virtual reality-based visual function testing. The partnership brings together ZEISS’ long-standing expertise in ophthalmic diagnostics and perimetry with Envision’s software-driven approach to digital eye health and immersive VR technologies. The companies aim to strengthen the clinical credibility and adoption of virtual reality tools that can help assess visual function while improving accessibility and patient experience in glaucoma care.
The collaboration comes as healthcare providers seek more flexible and scalable approaches to vision testing, particularly as demand for glaucoma screening and monitoring continues to grow. Traditional visual field testing often requires specialized equipment and in-clinic visits, creating barriers for some patients. By leveraging virtual reality and software-based testing methods, the partners hope to develop more portable and patient-centered solutions that can expand access to visual function assessments while maintaining the clinical rigor needed for diagnosis and disease management.
Envision Health Technologies was founded by glaucoma specialist Dr. Lama Al-Aswad with a focus on developing data-driven tools for vision care. Through this partnership, the company’s expertise in VR-based testing will be combined with ZEISS’ decades of experience in visual field analysis and ophthalmic innovation. Together, the organizations plan to help shape the future of VR perimetry and glaucoma diagnostics, supporting new approaches that may improve screening, monitoring and long-term management of vision-threatening eye diseases.
Click here to read the original news story.
